BPROAD
2025
Blood Pressure Control Targets in Diabetes
In 12,821 patients with type 2 diabetes, intensive blood-pressure control to below 120 mm Hg reduced major cardiovascular events compared with a target below 140 mm Hg.
Result
Efficacy: Major cardiovascular eventsHR 0.79
Below 1 favours intensive blood-pressure control to below 120 mm Hg, above 1 favours a target below 140 mm Hg.
Also reported: (21 % RRR); more hyperkalaemia in the intensive arm.
- Subtopic
- BP target
- Design
- Open-label RCT
- Relevance
- Important: one of several pillars.
- Cited in
- ACC/AHA 2025 Hypertension
- Source
- Bi Y, et al. N Engl J Med. 2025;392(12):1155-1167.doi 10.1056/NEJMoa2412006
Discussion & critique
Overturns the neutral ACCORD-BP result and extends the intensive target to diabetes. Chinese cohort; monitoring for AKI and hyperkalaemia is essential.